Luz Nagle

Reactive Myelopoiesis Triggered by Lymphodepleting Chemotherapy Limits the Efficacy of Adoptive T Cell Therapy

Patrick Innamarato, Krithika N. Kodumudi, Sarah Asby et al. · Molecular Therapy · 2020 · 51 citations · Full text

Medicine, Immunology, Oncology +17

Combination Nivolumab, CD137 Agonism, and Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes for Patients with Metastatic Melanoma

MacLean Hall, John E. Mullinax, Cheryl A. Cox et al. · Clinical Cancer Research · 2022 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17

Neoantigen-specific CD4⁺ tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patients

MacLean Hall, Jamie K. Teer, Xiaoqing Yu et al. · Journal for ImmunoTherapy of Cancer · 2023 · 36 citations · Full text

Life Sciences, Immunology, Oncology +17

Building a strong foundation from the ground up: the impact of a medical student substance use disorder organization on curriculum and community

Luz Nagle, Tabitha E.H. Moses, Anirudh Chitale et al. · Journal of Addictive Diseases · 2022 · 16 citations · Full text

Nursing, Higher Education, Medical Education +8

Early Recovery of Myeloid-Derived Suppressor Cells After Allogeneic Hematopoietic Transplant: Comparison of Post-Transplantation Cyclophosphamide to Standard Graft-Versus-Host Disease Prophylaxis

Benjamin Oshrine, Patrick Innamarato, Holly Branthoover et al. · Transplantation and Cellular Therapy · 2022 · 11 citations

Life Sciences, Hematology, Immunology +14